Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.
Saved in:
| Title: | Reply to Rappaport et al.: Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19. |
|---|---|
| Authors: | Dutt T; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Simcox D; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Downey C; Liverpool Clinical Laboratories Liverpool, United Kingdom and., McLenaghan D; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., King C; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Gautam M; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom., Lane S; University of Liverpool Liverpool, United Kingdom., Burhan H; Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom. |
| Source: | American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Dec 15; Vol. 202 (12), pp. 1733-1734. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
